Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index; 36 of the 74 sources its claims cite were checked for support.
Abstract
Despite its abundance in the environment, iron is poorly bioavailable and subject to strict conservation and internal recycling by most organisms. In vertebrates, the stability of iron concentration in plasma and extracellular fluid, and the total body iron content are maintained by the interaction of the iron-regulatory peptide hormone hepcidin with its receptor and cellular iron exporter ferroportin (SLC40a1). Ferroportin exports iron from duodenal enterocytes that absorb dietary iron, from iron-recycling macrophages in the spleen and the liver, and from iron-storing hepatocytes. Hepcidin blocks iron export through ferroportin, causing hypoferremia. During iron deficiency or after hemorrhage, hepcidin decreases to allow iron delivery to plasma through ferroportin, thus promoting compensatory erythropoiesis. As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroportin to blood plasma, thus limiting iron availability to invading microbes. Genetic diseases that decrease hepcidin synthesis or disrupt hepcidin binding to ferroportin cause the iron overload disorder hereditary hemochromatosis. The opposite phenotype, iron restriction or iron deficiency, can result from genetic or inflammatory overproduction of hepcidin.
Overview
CoChat Summary
TL;DR
The review describes how hepcidin binding to ferroportin controls systemic iron homeostasis by blocking cellular iron export, thereby regulating plasma iron, erythropoiesis, and host defense. Dysregulation of this axis causes iron overload such as hereditary hemochromatosis or iron-restrictive anemias, making it a therapeutic target.
Key findings
- Hepcidin, a 25-amino-acid peptide (MW 2.8 kD) present at approximately 2–20 nM in healthy humans, binds ferroportin (SLC40A1; 571 amino acids, ~65–70 kD) and inhibits iron export by occluding the open-outward conformation and inducing endocytosis/degradation.
- Ferroportin exports iron from duodenal enterocytes, iron-recycling macrophages, and hepatocytes; adult humans have total body iron of approximately 3–4 g with daily losses of only 1–2 mg, while plasma transferrin holds only 2–3 mg of iron but delivers 20–25 mg/day.
- The erythron contains approximately 2–3 g of iron, about 2/3–3/4 of total body iron; hepatocyte stores contain up to 1 g, the spleen normally about 0.05 g, and other tissues about 0.3 g.
- Loss of hepcidin or disrupted hepcidin binding to ferroportin causes hereditary hemochromatosis; excessive hepcidin, such as from TMPRSS6 mutations, causes iron-refractory iron deficiency anemia (IRIDA), and inflammatory hepcidin increases produce hypoferremia and nutritional immunity.
Methods
- Narrative review synthesizing published literature; no primary experimental design, sample, or statistical analysis is reported.
- The text integrates structural, genetic, physiological, and clinical evidence from cited studies, including mouse models and human disease examples.
- Not stated in the paper: systematic search strategy, inclusion/exclusion criteria, or data-extraction methods.
Limitations
- The paper states unresolved issues: how ferroportin’s two divalent metal-binding sites mediate export is not clear; the energetics of iron export are not well characterized; functional consequences of tissue-specific ferroportin glycosylation are not understood; the quantitative contribution of hepcidin clearance mechanisms is unknown; and the physiological role of microRNA regulation is uncertain.
- Evident from the text: as a narrative review, it lacks a described systematic search or formal quality assessment, so conclusions depend on selected cited literature.
- Not stated in the paper: an explicit limitations section or discussion of publication bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].](https://figures.cochat.ai/paper-figures/a8d0b48e97e349ad9b7b164106596b50/hepcidin-ferroportin-interaction-controls-systemic-iron-homeostasis-figure-3.jpg)


Verification
Claims the paper makes
31 Valid · 2 Not valid · 28 Not checked · 21 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Because iron is exported against the force exerted by the transmembrane electric field, and there is no evidence of direct coupling of the transport to ATP hydrolysis, the export of iron is likely facilitated by the coupled “downhill” transport of another ion or small molecule [13].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 4. Ferroportin Structure
What the sources say
- Disputedcites [13] Deshpande, 2018, Calcium is an essential cofactor for metal efflux by the ferroportin transporter family, Nat. Commun. sourceExperimental — accuracy not yet measured
The Results section reports that iron efflux does not depend on a transmembrane H+ gradient or Na+, and experiments do not support Fe2+/Ca2+ antiport. The paper instead identifies extracellular Ca2+ as a cofactor that activates ferroportin without being transported. These findings run contrary to the proposed downhill-coupled transport mechanism. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Efficient filtration of hepcidin in the glomerulus is facilitated by the relatively low fraction of hepcidin that is bound by plasma protein, estimated at about 40% [28].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 6. Hepcidin Synthesis and Elimination
What the sources say
- Partly supportedcites [28] Diepeveen, L.E., Laarakkers, C.M., Peters, H.P.E., van Herwaarden, A.E., Groenewoud, H., IntHout, J., Wetzels, J.F., van Swelm, R.P.L., and Swinkels, D.W. (2019). Unraveling hepcidin plasma protein binding: Evidence from peritoneal equilibration testing. Pharmaceuticals, 12. sourceExperimental — accuracy not yet measured
The Abstract reports a hepcidin protein-bound fraction of 40% (±23%), and the Discussion says hepcidin is not predominantly bound and is rapidly excreted by the kidneys. The study used peritoneal dialysis in patients with end-stage renal disease; it does not establish that low protein binding facilitates efficient filtration in the glomerulus. (LLM, conf=0.86)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study [21] provide convincing evidence that Rnf217 is an important E3 ubiquitin ligase that triggers the degradation of ferroportin in response to hepcidin binding.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Supportedcites [21] Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., and Song, Z. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. source
The Introduction states that hepcidin binds ferroportin and induces its internalization and degradation. The Results report that RNF217’s E3 ubiquitin ligase activity is required for ferroportin degradation and that hepcidin-mediated degradation is at least partially RNF217-dependent in mice. The paper also notes that RNF217 can promote degradation without added hepcidin in vitro, so the response to hepcidin is not its only observed mode of action. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, duodenal iron absorption increases several-fold after blood loss or exposure to hypoxia, or in response to iron deficiency.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 2. Iron Compartments and Flows
What the sources say
- Partly supportedcites [3] Finch, 1994, Regulators of iron balance in humans, Blood sourceExperimental — accuracy not yet measured
The Store Regulator (p. 2) says absorption is high when iron stores are depleted, and The Erythroid-Regulator (p. 3) reports increased absorption after phlebotomy and in iron-deficiency anemia. The latter section links hypoxia to erythropoietin release, but does not report a several-fold rise in duodenal absorption after hypoxia exposure; it also does not establish a several-fold increase for each condition in the claim. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Partly supportedcites [14] Billesbolle, 2020, Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms, Nature sourceExperimental — accuracy not yet measured
The hepcidin-binding section (p. 6) supports the role of a C-domain metal site: iron greatly increases hepcidin affinity, and mutations at that site weaken binding. But the cited paper identifies the coordinating cysteine as C326, not C325; C325 is not the cysteine named in this claim. The structure directly shows cobalt, an iron mimetic, at the site. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
44 more claims · 19 with their cited sources checked
Create a free account to see all 82 claims and to verify the 10 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 3
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
“the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 7. Evidence for Exclusivity of the Hepcidin-Ferroportin Ligand-Receptor Dyad
“the essential conserved amino acid at the ferroportin binding site for hepcidin, C326 (human numbering)”
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 3×
“The flow of iron out of the cells is controlled by hepcidin through two known mechanisms: occlusion of the open-outward conformation of ferroportin by hepcidin [17], and hepcidin-induced endocytosis and degradation of ferroportin [4].”
BackgroundSelf-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“Infection and inflammation induce hepcidin, predominantly through the effects of the cytokine interleukin-6 (IL-6) [52], and increased concentrations of hepcidin then inhibit ferroportin activity, leading to depletion of iron in plasma and extracellular fluid (hypoferremia).”
BackgroundSelf-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundSelf-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · cited 1×
“During pregnancy, ferroportin is very highly expressed on the basal surface of syncytiotrophoblast in the placenta [7,50], where it plays an indispensable role in iron transfer to the fetus.”
BackgroundMcKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Zimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405 · cited 1×
“Iron deficiency, iron deficiency anemia [65] and anemia of inflammation [66] are very common disorders affecting a large portion of the population.”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Cited by
Items 401–500 of 530
Liu, H., Song, Z., He, X., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4466362 · Cited by 1
Yang, W.-P., Li, M.-Q., Ding, J. M., Li, J., Wu, G., Liu, B., Gao, Y., Wang, G., & Luo, Q. (2023) · eLife · doi:10.7554/elife.87496.2 · Cited by 2
Vera‐Aviles, M., Kabir, S., Shah, A., Polzella, P., Lim, Y., Buckley, P., Ball, C., Swinkels, D. W., Matlung, H. L., Blans, C., et al. (2024) · medRxiv · doi:10.1101/2024.01.18.24301496 · Cited by 1
“Specialised organs of iron handling, such as the spleen and liver, are characterised by high iron storage capacity and rapid iron turnover owing to abundant levels of ferritin and ferroportin respectively ,28,29,40 .”
BackgroundHepcidin, Anemia, and Liver Diseases
Arshad, S. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.40.006422
Hereditary anemias: more complex than ever
van Vuren, A. J. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/429
Relación entre la anemia infantil y el desempeño intelectual en la juventud
Solano, J. P. (2022) · Boletín de la Sociedad Peruana de Medicina Interna/Revista de la Sociedad Peruana de Medicina Interna · doi:10.36393/spmi.v35i1.650
The full blood count and blood film in healthy term and preterm neonates
Roberts, I. A. G., & Bain, B. J. (2022) · Wiley eBooks · doi:10.1002/9781119371601.ch1
Serum hepcidin levels as indicator of anemia status in male hemodialysis patients
Ulrahman, B. A. A., & Sharba, I. R. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.8526
“The statistical analysis in the Table (1) indicated to 90 samples consisted of 65 HD patients with median (IQR) dialysis vintage was (12 (3-36) month, compared with 25 healthy participates as control group.”
MethodAnother tool in the toolkit to manage iron overload
Philpott, C. C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208868119
“activities of ferroportin and the major regulatory hormone, hepcidin (6).”
BackgroundHepcidin-induced degradation of iron exporter ferroportin determines anemia of chronic diseases
Mukhopadhyay, C. K., Mishra, P., Aggarwal, A., & Yadav, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91305-8.00016-8
Zou, Z., Gao, X., Gao, X., Yao, Y., Yao, Y., Gan, X., Gan, X., Liu, J., Liu, J., Lei, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2216456/v1
Patent Highlights June–July 2022
Mucke, H. A. (2022) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2022-0043
Anemia feriprivă – manifestare de debut al unei boli celiace oculte
Baciu, A. M., Roşca, A., Căpuşă, C.-S., Iordan, I., & Vlădăreanu, A. M. P. D. (2022) · Oncolog-Hematolog ro · doi:10.26416/onhe.60.3.2022.7153
Iron deficiency in cardiac surgical patients
Hof, L., Old, O., Steinbicker, A. U., Meybohm, P., Choorapoikayil, S., & Zacharowski, K. D. (2022) · Acta Anaesthesiologica Belgica · doi:10.56126/73.4.28
Yang, W.-P., Li, M.-Q., Ding, J. M., Li, J., Wu, G., Liu, B., Gao, Y., Wang, G., & Luo, Q. (2023) · eLife · doi:10.7554/elife.87496.1
La hepcidina y sus implicancias en las estrategias de suplementación con hierro
Chávez-Barriga, J. C., Huamaní, A. C., & Yarleque-Mujica, J. A. (2023) · Revista Médica Herediana · doi:10.20453/rmh.v34i3.4930
Effectiveness of novel iron regulators in the treatment of diabetic nephropathy
Banerjee, D., Kaur, G., Chatterjee, B., et al. (2023) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2023.3.28
Features of regulation of hepcidin and ferroportin in cancer patients (literary review)
Blindar, V. N., Зубрихина, Г. Н., Давыдова, Т. В., & Dobrovolskaya, M. M. (2023) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2023-22-3-10-18
Dapagliflozin alleviates high-fat-induced obesity cardiomyopathy by inhibiting ferroptosisPreprint
Chen, D., Shi, J., Xuan, T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3439522/v1
Study of Synthesit iron citrate effect in multiple organ metabolic syndrome
Oynotkinova, O. S., Мацкеплишвили, С. Т., Maslennikova, O. M., & Pavlov, А. I. (2023) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20232610170
Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Lin, C.-A., Hayashi, N., Badenhorst, C. E., & Goto, K. (2023) · Nutrients · doi:10.3390/nu15234924
“Ferroportin is internalized and degraded after binding, which leads to reductions in iron absorption by enterocytes and iron recycling by macrophages [9,10].”
BackgroundWu, Y., Li, Y., Miao, Y., Wei, H., Luo, H., Ren, C., Zhang, Y., Chen, J., Wei, T., Deng, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3692108/v1
Debbiche, R., Ka, C., Gourlaouen, I., Maestri, S., Uguen, K., Jaffrès, P., Callebaut, I., & Gac, G. L. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.14.571614 · Cited by 1
Juneja, P., Rashid, N., Qais, F. A., Tanwar, S., Sultan, I., Ahmad, F., & Rehman, S. U. (2024) · IUBMB Life · doi:10.1002/iub.2809
“5 The elevated levels of iron cause an increase in the expression of hepcidin which binds to FPN and subsequently leads to its internalization, ubiquitination, and degradation thereby resulting in inhibition of iron efflux into the blood stream.”
Iron deficiency in inflammatory bowel disease
Loveikyte, R. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.926089185
Yang, W.-P., Li, M.-Q., Ding, J. M., Li, J., Wu, G., Liu, B., Gao, Y., Wang, G., & Luo, Q. (2024) · eLife · doi:10.7554/elife.87496.3
Alcohol-induced hepatic fibrosis and the relation between Hepcidin and liver fibrosis
Ali, A.-S. A., Aborehab, N. M., Saleh, S. M., & Mehanna, E. T. (2024) · Records of Pharmaceutical and Biomedical Sciences/Records of Pharmaceutical & Biomedical Sciences · doi:10.21608/rpbs.2024.221578.1239
Zeng, L., Wang, Y., Ai, C., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4848232
Nalin, T., Sperb‐Ludwig, F., Siebert, M., Rizowy, G. M., Weinstein, D. A., Derks, T. G. J., de Souza, C. F. M., & Schwartz, I. V. D. (2024) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1590/2326-4594-jiems-2023-0015
Yang, M., Tang, C., Peng, F., Luo, C., Chen, G., Kong, R., & Peng, P. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1416014 · Cited by 1
The influence of micronutrients and macronutrients excess or deficiency on thyroid function
Brzdęk, K., Wisniewski, S. R., Domańska, O., Baran, W., & Brzdęk, M. (2024) · The Ukrainian Biochemical Journal · doi:10.15407/ubj96.04.005
Bile from the hemojuvelin-deficient mouse model of iron excess is enriched in iron and ferritin
Prajapati, M., Chiu, L., Zhang, J. Z., Chong, G. S., DaSilva, N. A., & Bartnikas, T. B. (2024) · Metallomics · doi:10.1093/mtomcs/mfae043
Makarova, N. A. (2024) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2024-102-5-6-454-467
Ginzburg, Y. Z., & Vinchi, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-96014-4.00067-7
Conway, B. N., Pratte, K., Bowler, R. P., Young, K. A., Kinney, G. L., Austin, E. E., Li, Y., McClain, D. A., Hokanson, J. E., & Crapo, J. D. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s492124 · Cited by 1
Arnould, B., Martz, A., Belzanne, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.24.634652
Dremiski, G., Hoffmann, A. D. S., & Ito, V. C. (2025) · Food Science Today · doi:10.58951/fstoday.2025.001
The Fight for Iron: A Central Theme in Host-Pathogen Interactions
Hamad, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_11 · Cited by 1
Ferreira, A. P. O., Pino, J. M. V., da Luz, M. H. M., Petrucci, T. V. B., de Souza, G. O., Donato, J., & Lee, K. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.04.641404
Research Progress on the Effects of Iron on Human Body
王, 洪. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153659
Iron-refractory iron deficiency anemia in children: first genetically confirmed cases in Russia
Lunyakova, M. A., Demikhov, V. G., Inyakova, N. V., & Raykina, E. V. (2024) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2024-23-4-138-143 · Cited by 2
Goryacheva, O. G., & Zubarev, M. A. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-3-30-34
Duodenal Lamina Propria Transferrin—A New Player in the Mucosal Block of Dietary Iron Absorption?
Ramasamy, J. (2025) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0262
Jian, A., Huang, Y., Tian, X., & Ai, C. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5270860
Iron repletion in heart failure: a symptomatic win, a survival miss
Monzo, L., Cheema, B. S., Ambrosy, A. P., et al. (2025) · Heart Failure Reviews · doi:10.1007/s10741-025-10532-z
“In this setting, ID typically results from impaired iron absorption in the duodenum or reduced iron release from the reticuloendothelial system, often due to inflammation or cellular stress, which increase hepcidin and ferritin levels [3].”
Wande, I. N., Linawati, N. M., Dewi, P. P. A. P., et al. (2025) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v31i3.2395
Correlation Study of Interleukin-6 in Patients with Anemia of Inflammation and Chronic Periodontitis
沈, 子. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1561865
Liu, J., Yang, W., Song, L., Chen, X., Yin, X., Li, M., Bai, X., Yang, Z., Wang, Z., Guo, W., et al. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2521454 · Cited by 2
“Hepcidin plays a role in regulating iron homeostasis by reducing the release of stored iron from the liver [35]. although not directly measured, we speculate that the efficient filtration of hepcidin by Pd may result in elevated serum iron and tiBC, which ultimately influences brain iron levels…”
HFE mutations in patients with iron overload in Santa Catarina: a cross-sectional study
Pagliosa, C. M., Franco, V. K. B., Matias, T. S., Dias, B. V., & Hoepers, A. T. D. C. (2025) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2023.0359.r1.07032025
Ferric Carboxymaltose (Ferinject)
CDA-AMC (2025) · Canadian Journal of Health Technologies · doi:10.51731/cjht.2025.1168
Zhilenkova, Y. I., Simakova, M. A., Алексеевна, З. Е., Goncharova, N. S., Karelkina, E. V., Моисеева, О. М., & Вавилова, Т. В. (2025) · Translational Medicine · doi:10.18705/2311-4495-2025-12-3-214-224
KOPYLCHUK, Н. P., Nykolaichuk, I., & MISIURA, S. V. (2024) · Biolohichni systemy · doi:10.31861/biosystems2024.02.231
Chen, S., Chang, T., Luo, J., Zhang, C., Zhang, P., Gu, S., Lin, Z., Chen, Y., Shen, Y., Dong, L., et al. (2025) · Inflammation Research · doi:10.1007/s00011-025-02074-9 · Cited by 1
Algül, M., Mete, F., Bostan, G. O., Erol, M., & Özdemir, N. (2025) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000003083
Huang, N., Huang, H., Zheng, X., Chen, Z., Wang, Y., & Zhang, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-18427-7 · Cited by 2
“Since high levels of SF stimulate the transcription of Hepcidin 34 , which then inhibits iron absorption and promotes iron utilization to reduce circulating iron levels, the two are theoretically positively correlated 14,26,30,31 .”
Saeed, M., & Mohammed, L. Y. (2025) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-02171-z · Cited by 1
Features of diagnosis and treatment of iron deficiency anemia in women of reproductive age
Leshcheva, M. Y., Korotkih, I. N., Korichkina, L. N., et al. (2025) · Vrach · doi:10.29296/25877305-2025-08-05
Anemic syndrome in patients with rectal cancer
Blindar, V. N., & Klimanov, I. A. (2025) · Russian Journal of Biotherapy · doi:10.17650/1726-9784-2025-24-3-63-69
The Role of Anemia of Inflammation in the Course of Chronic HBV Infection in Children
Il’yasovna, I. F., Anvarovna, I. N., Zakhidjanovna, I. G., Marufovna, K. K., Gafurovna, A. F., & Kabildjanovna, V. N. (2025) · Journal of Advanced Pediatrics and Child Health · doi:10.29328/journal.japch.1001074
Соломахина, Н. И., Dementyeva, A., & Sokolov, А. А. (2025) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6288
Особливості показників обміну заліза в пацієнтів із дисфункцією щитоподібної залози
Urbanovych, A., & Yuskiv, M. V. (2025) · Endokrynologia · doi:10.31793/1680-1466.2025.30-3.223
Saeed, M., & Mohammed, L. Y. (2025) · Clinical & Translational Metabolism · doi:10.1007/s12018-025-09317-7
“In cases of iron deficit or post-hemorrhage, hepcidin levels diminish to facilitate iron transport to plasma via ferroportin, hence enhancing compensatory erythropoiesis [16, 17].”
Rocco, S., Panuzzo, C., Schiavo, V., Balsano, G., Ferrando, A., & Pergolizzi, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-21796-8
Hepcidin in ischemic acute kidney injury: mechanistic advances and unanswered questions
Aphale, P., Shekhar, H., & Dokania, S. (2025) · Kidney International · doi:10.1016/j.kint.2025.09.004
Manougian, H., & Talati, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-97759-6_10
Guerrab, W., Lepage, M., Désilets, A., Joushomme, A., Desgagné, M., Froehlich, U., Leduc, R., & Boudreault, P. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01998
Cao, A.-M., Duruz, J., de Almeida, M. S., Vanhecke, D., Alston, A. E. B., Digigow, R. G., Flühmann, B., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-27257-6
“Moreover, addressing this research gap can facilitate understanding of how diseases commonly treated with iron-carbohydrate complexes affect the biodisposition, especially highly prevalent diseases associated with concomitant inflammatory burdens (e.g. chronic kidney disease and heart failure) 27 .”
Chen, L., Liu, G., Liu, S., Zhu, Y., Liu, Z., Wei, L., Liao, Y., Ye, Y.-F., Huang, W., Liu, W., et al. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112994 · Cited by 2
Shi, J., Chen, D., Wang, Z., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23575329
Bai, X., Wang, B., Cui, Y., Tian, S., Zhang, Y., You, L., Chang, Y.-Z., & Gao, G. (2024) · Figshare · doi:10.6084/m9.figshare.26665882
Ferreira, A. P. O., Araujo, K. A. D., Pino, J. M. V., Petrucci, T. V. B., da Luz, M. H. M., de Souza, G. O., Glezer, I., Donato, J., & Lee, K. S. (2026) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.12.012
Hamed, H. M., Abdelhamid, N., Salama, H. M., Motawie, A. A., El-Bostany, E. A., Galal, A. A., Elghoroury, E. A., Kamel, S. A., Hassan, E. M., Helmy, N. A., et al. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-02267-6
Fen, L., Nan, D. H., Yu, L., Zhao, J., & Zhong, G. X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1685793
“When these storage cells are damaged, ferritin is released into the bloodstream in large quantities, creating a vicious cycle of “cellular iron overload → cellular damage → serum ferritin elevation” (14–18).”
Spencer, S., Lynn, G., Wheeler-Jones, C. P. D., et al. (2026) · Journal of Veterinary Internal Medicine · doi:10.1093/jvimsj/aalaf010
The research progress of ferroptosis in acute lung injury
Bai, Y., Ma, Y., & Li, X. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102434
“Emerging evidence indicates that ferroptosis is mechanistically linked to altered expression of key iron regulatory proteins, including hepcidin [31], divalent metal transporter-1 (DMT1), and ferritin.”
Intestine-Specific Ferroportin Ablation Rescues from Systemic Iron Overload in Mice
Castillo, C., GIM, S. C. M. M. F. F., & Das, N. K. (2026) · Nutrients · doi:10.3390/nu18020352
“…absorption is regulated by two interdependent pathways: (i) local regulation via hypoxia-inducible factor (HIF)-2 α - dependent transport [5] and (ii) systemic regulation via the hepcidin–Fpn1 axis, in which hepatic hepcidin limits intestinal iron efflux by inducing Fpn1 degradation [6] (Figure 1).”
Zhao, Q., Kai Hong, S. U. N., Wu, X., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-15608-z
“Concur-rently, inflammation stimulates hepcidin synthesis, which inhibits intestinal iron absorption and macrophage iron recycling, leading to functional iron deficiency [9, 10].”
Wu, S., Li, P., Liu, Q., Zhang, K., Ding, X., Wang, J., Zeng, Q., Liu, Y., Xuan, Y., Li, S., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1725052
“Hepcidin is not only central to iron homeostasis but is also regulated by and may influence metabolic processes (29).”
The Current State and Breakthroughs in Research on Iron Deficiency Anemia during Pregnancy
卢, 妍. (2026) · Medical Diagnosis · doi:10.12677/md.2026.161009
ROS and Ferroptosis Impact on Inflammation-Mediated Hemochromatosis
Gobinath, M., Roychowdhury, P., Sarkar, P., Maideen, N. M. P., & Chatterjee, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_16
Henafy, H. M. A. E., Nashar, E. M. E., Zafrah, H. A., El‐Khadragy, M. F., Alkhateeb, M. A., & Moneim, A. E. A. (2026) · Biological Trace Element Research · doi:10.1007/s12011-025-04961-y
Transferrin-dependent uptake and distribution of iron in osteoclast-like cells
Dolder, S., Cabra, R. S., Zaugg, J., Albano, G., Fuster, D. G., Albrecht, C., & Hofstetter, W. (2026) · Bone Reports · doi:10.1016/j.bonr.2026.101909
“Cellular iron concentrations are regulated by transferrin (TF) – transferrin receptor (TFRC) mediated iron uptake and by ferroportin (FPN, Slc40A1) mediated iron release (Donovan et al., 2000; Nemeth and Ganz, 2021).”
CELLULAR AND MORPHOLOGICAL MECHANISMS OF IRON ABSORPTION IN THE DIGESTIVE TRACT
Demydchuk, A. S., & Kondaurova, H. Y. (2026) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2026-1-180-54-61
A review of the iron requirements and its determination in commercial poultry
Morgan, N. K., O’Keeffe, J. L., & Hackett, M. J. (2026) · Animal nutrition · doi:10.1016/j.aninu.2026.01.002
Wu, C., Tian, C., Liao, L., Liu, L. F., Ye, Z., Chen, M., Huang, W., Yang, Q., & Lan, X. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1795475
“Nemeth et al. found that IL-6 induces ferritin degradation and inhibits ferroportin by upregulating hepatic hepcidin synthesis, leading to functional iron deficiency and the loss of volume uniformity in newly generated red blood cells (21).”
Zhang, B., & Zhang, M. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s596584
“36 The intracellular iron accumulation caused by the Hepcidin-FPN1 axis provides a basis for Fenton reactions, lipid peroxidation, and ultimate ferroptosis.”
Saed, A., Akbarzadeh, M., Gohari, F., Asadrouh, N., Jahromizadeh, A. M., Sabaie, H., Zarkesh, M., Hedayati, M., Azizi, F., & Daneshpour, M. (2026) · Human Genomics · doi:10.1186/s40246-026-00972-5
“SLC11A2 / DMT1 is a principal importer of ferrous iron at plasma and endosomal membranes, while TF is essential for iron transport and hepatic feedback regulation via hepcidin [6, 23, 24].”
InfluentialDea’a, M., & Santi, S. R. (2026) · Ibn Sina Journal of Medical Science Health & Pharmacy · doi:10.64440/ibnsina/sina0019
Portolés, J. M., Coll, E., Puchades, M. J., Broseta, J. J., Quiroga, B., Rodríguez, D., Bajo, M. A., Merino, J. L., Ojeda, R., de Sequera, P., et al. (2026) · Nefrología · doi:10.1016/j.nefro.2026.501576
Kaneko, M., Hsu, C.-F., Tsai, C.-T., Osana, S., Fujii, T., Ito, S., & Katsuhiko, H. (2026) · Nutrients · doi:10.64898/2026.05.14.725062
“Under inflammatory conditions, hepcidin promotes ferroportin degradation and consequent intracellular iron retention, which in turn drives compensatory FTH1 upregulation to safely sequester accumulated labile iron[19, 20].”
InfluentialCao, F., Ge, X., Pi, A., Huang, Q., Pei, L., Chen, R., Cao, W., Ding, Q., Yang, M., Song, Q., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10398-3
“Under physiological conditions, HEPCIDIN serves as a host defense mechanism by regulating circulatory and tissue iron homeostasis via controlling ferroportin-mediated iron ef fl ux from enterocytes (dietary iron absorption) and iron storage cells 54,55 .”
Hamidova, G. E., & Азизова, Г. И. (2025) · Azerbaijan Journal of Physiology · doi:10.59883/ajp.125
Yang, H., Chen, H., Cheng, F., et al. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1821139
“Its primary function is to maintain systemic iron homeostasis by modulating iron absorption, release, and storage (12, 13).”
Doğantan, Ş., Yücel, B. B., Perk, P., et al. (2026) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20251637
“High hepcidin levels lead to iron retention in macrophages and other cells; consequently, serum iron decreases, and functional iron deficiency anemia may develop 19 .”
Lucernoni, K. M., Chacon, S. J., Needham, K. W., Halliwill, J. R., & Minson, C. T. (2026) · Physiological Reports · doi:10.14814/phy2.70981
“If hepcidin is present in high concentrations, absorption of dietary iron into circulation is more difficult as ferroportin channels are integral to transporting iron into the circulation (Nemeth & Ganz, 2021).”
Zhou, Z.-R., Zhang, W.-J., Zhao, X.-Y., et al. (2026) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_1209_25
“[31] Iron imbalance can lead to immune deficiencies or alter immune cell functions, and iron plays a crucial role in the activation and differentiation of Th1, Th2, and Th17 cells, cytotoxic T lymphocytes (CTLs), and in the antibody responses of B cells.”
Thalapalliyil, K., Bobby, Z., Dorairajan, G., & Toi, P. C. (2026) · Placenta · doi:10.1016/j.placenta.2026.06.017 · Cited by 1
Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP–SMAD Signaling to Therapeutic Modulation
Duminuco, A., Costa, A. N., Pilo, F., Scarso, S., Giallongo, C., Giallongo, S., Santisi, A., Sbriglione, A., Santocono, L., Caocci, G., et al. (2026) · Biomolecules · doi:10.3390/biom16070947 · Cited by 3
“Hepcidin also appears to function in part as a direct blocker of ferroportin’s iron-transport activity before internalization, consistent with rapid (within minutes) reductions in plasma iron after hepcidin administration [26,27].”
Epigenetic regulation of the hepcidin gene expression in hepatoma cells
Yasuda, A., Hayashi, K., Sakota, S., Kanamori, Y., Shimokawa, F., Murakami, M., & Funaba, M. (2026) · FEBS Journal · doi:10.1111/febs.70645
Metadata
- Authors
- Nemeth, E., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-17
- Volume
- 22
- Issue
- 12
- Pages
- 6493
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8235187
- OpenAlex
- W3172506357
- Semantic Scholar
- 8da9eb7ee1579f5db94cd40eca5fde949bb5967c
- Cited by
- 540
- References
- 69
- Citations by year
- 2026: 101 · 2025: 143 · 2024: 107 · 2023: 110 · 2022: 71 · 2021: 7
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD096863)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hepcidin, ferroportin, SLC40A1, iron homeostasis, iron export, hypoferremia, compensatory erythropoiesis, iron deficiency, hereditary hemochromatosis, inflammation, infection, iron overload, iron recycling, macrophages, hepatocytes
- MeSH terms
- Ferroportin, Animals, Biological Transport, Disease Susceptibility, Homeostasis, Humans, Iron, Ligands, Protein Binding, Tissue Distribution, Signal Transduction, Autocrine Communication, Paracrine Communication, Cation Transport Proteins, Metabolic Networks and Pathways, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.